Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes (2016 - 2025)

Cumberland Pharmaceuticals' Other Working Capital Changes history spans 16 years, with the latest figure at -$129233.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 114.87% year-over-year to -$129233.0; the TTM value through Dec 2025 reached -$477642.0, down 210.62%, while the annual FY2025 figure was -$477642.0, 210.62% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$129233.0 at Cumberland Pharmaceuticals, down from $92033.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.8 million in Q4 2022 and bottomed at -$1.2 million in Q3 2022.
  • The 5-year median for Other Working Capital Changes is -$371214.0 (2022), against an average of -$98159.8.
  • The largest YoY upside for Other Working Capital Changes was 1519.29% in 2021 against a maximum downside of 1006.19% in 2021.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.7 million in 2021, then grew by 7.23% to $1.8 million in 2022, then tumbled by 121.51% to -$383612.0 in 2023, then surged by 326.52% to $868947.0 in 2024, then plummeted by 114.87% to -$129233.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Other Working Capital Changes are -$129233.0 (Q4 2025), $92033.0 (Q3 2025), and -$380071.0 (Q2 2025).